Illumina, Inc. vs Quantumscape Corp — how do they compare? Illumina, Inc. trades at $184.68 (market cap $27.94B), while Quantumscape Corp trades at $6.06 (market cap $3.62B). The key difference: Illumina, Inc. is far larger — about 7.7× Quantumscape Corp's market cap, and Illumina, Inc. is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals.
| ILMN | QS | |
|---|---|---|
Market Cap | $27.94B | $3.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $194.33 | $18.44 |
52-Week Low | $91.00 | $5.86 |
Enterprise Value | $29.33B | $2.79B |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →